^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Small Cell Lung Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published date:
04/14/2021
Excerpt:
Recommendations: In extensive-stage, cisplatin can be substituted with carboplatin [I, B].
DOI:
10.1016/j.annonc.2021.03.207
